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Abstract
Background: Avian origin canine influenza virus was reported in Korea. The dog to dog contact transmission of
the avian origin canine influenza virus (CIV) H3N2 and CIV H3N8 was shown by experimental contact transmission.
This study was focused on viral excretion and fever in order to elucidate the epidemiological associations which
might be helpful to control the disease transmissions in CIV outbreak in dogs.
Methods: An influenza seronegative 10-week-old Beagle dog was experimentally inoculated with the canine
influenza virus A/canine/01/2007, subtype H3N2. Eight hours after inoculation, the infected dog was cohoused with
seven uninfected Beagle dogs. Clinical signs including fever were recorded for 14 days post inoculation.
Results: The infected dog and four of seven contact dogs in the study showed clinical signs (sneezing, nasal
discharge and coughing) during the study. Viral shedding occurred in all of the animals tested and began on 1
to 6 DPI in dogs with clinical signs. Elevated body temperatures above 39.5°C (geometric mean temperature of
39.86°C±0.49) were observed in all symptomatic dogs. The mean viral titer during fever was 2.99 log EID50/ml,
which was significantly higher than the viral titer detected in the non fever.
Conclusions: The data show that contact dogs with a canine influenza infected dog shed different levels of virus
in their nasal excretions and demonstrate that clinical signs, including fever, significantly correlate with the viral
shedding.
Background
Canine influenza virus infection caused severe and acute
respiratory symptoms in infected dogs [1-4]. Especially
avian origin canine influenza virus was reported in
Korea [2]. The experimental or natural infection of type
A influenza virus infection of the dogs from human
[5,6] and horse [3,7] were reported. The dog to dog con-
tact transmission of the avian origin canine influenza
virus (CIV) H3N2 [1] and CIV H3N8 [8] was shown by
experimental contact transmission. Regardless of sub-
type, H3N8 or H3N2 CIV could infect nascent indivi-
duals and causes clinical signs [1,8]. The study about
experimental transmission of H3N8 CIV in dogs showed
that significant relation between the viral load and clini-
cal signs as dictated in textbook [8,9].
Clinical signs caused by influenza virus were diverse
respiratory signs including cough, sneezing, pneumonia,
myositis, cardiac dysfunctions, and central nervous syn-
drome[10]. However, fever is the most significant clini-
cal feature in influenza virus infection. It was predicted
that the cause of fever would be pyrogenic cytokines
including tumor necrosis factor-a,i n t e r l e u k i n ,a n d
interferon [11].
This study was focused on two points, viral excretion
and fever. The relation between clinical signs, especially
fever, and viral excretion via nasal shedding in order to
elucidate the epidemiological associations, which might
be helpful to control the disease transmissions in CIV
outbreak in dogs.
Methods
An influenza-seronegative 10-week-old Beagle dog was
experimentally inoculated with the avian origin canine
influenza virus A/canine/01/2007, subtype H3N2, which
was originally isolated from a pet dog with severe
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any medium, provided the original work is properly cited.respiratory syndrome [2]. Eight hours after inoculation,
the infected dog was cohoused with seven uninfected
Beagle dogs in the animal facilities at Green Cross
Veterinary Products (Yongin, South Korea). All animal
experiments complied with the current laws of South
Korea. Animal care and treatment were conducted in
accordance with guidelines established by the Green
Cross Veterinary Products Institutional Animal Care
and Use Committee.
Clinical signs (sneezing, nasal discharge and coughing)
and rectal temperatures were recorded daily for 14 days
post-inoculation (DPI), and nasal swab samples for the
detection of viral shedding were also collected daily over
the same time course. Serum samples were collected on
days 0, 7, and 14, and antibodies against nucleoprotein
(NP) were detected by a commercial canine influenza
virus (CIV) competitive ELISA (Animal Genetics, Inc.,
Suwon, South Korea) [1].
To investigate the correlation between fever and viral
shedding, the mean viral titers in the nasal discharge
were examined during fever (body temperature >39.5°C)
and non-fever stages.
Results
Clinical finings
The infected dog and four of seven contact dogs in the
study showed clinical signs (sneezing, nasal discharge
and coughing) during the study, while 3 dogs lacked
symptoms. All of the animals seroconverted as assessed
by a CIV competitive ELISA (data not shown). Clinical
signs were observed from 4 to 8 DPI, and viral shedding
was detected earlier in dogs with clinical signs than
those without (Figure 1).
Viral shedding and body temperature
Viral shedding occurred in all of the animals tested and
began on 1 to 6 DPI in dogs with clinical signs, but was
not detected until day 9 DPI in symptom free dogs. The
viral titers shed by dogs with clinical signs were also
higher than those shed by asymptomatic dogs. Specifi-
cally, viral titers were higher than 3 log EID50/ml at any
time post-challenge in dogs with clinical signs but
remained less than 1.6 log EID50/ml in those without
clinical signs.
Body temperature (°C) was also monitored during the
study, and increases in body temperature correlated with
the level of viral shedding as well. Elevated body tempera-
tures above 39.5°C (39.86°C ± 0.49) were observed in all
symptomatic dogs, while the body temperatures of all dogs
without clinical signs remained below 39.5°C (38.68°C ±
0.41). The mean viral titer during fever was 2.99 log
EID50/ml, which was significantly higher than the viral
titer detected in the non fever (0.78 log EID50/ml; p <<
0.001, Student’s T-test) (Figure 2).
Figure 1 Levels of CIV shed in the nasal discharge of dogs with and without clinical signs. The daily levels of viral shedding are expressed
as the log EID50/ml from five individual dogs with clinical signs (A) and three dogs without clinical signs (B). Body temperatures (°C) were also
compared between dogs with (C) and without (D) clinical signs.
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Interspecies transmission of influenza viruses, especially
highly pathogenic avian H5N1, is a possible threat to
global human health [12]. Successful interspecies trans-
mission of the avian influenza virus H3N2 to dogs and
subsequent intraspecies transmission between dogs has
been reported previously [1,2]. These data suggest that
avian influenza viruses can traverse interspecies (avian
to mammal) transmission barriers, which in turn sug-
gests the possibility for transmission of influenza viruses
from birds to humans.
Since influenza virus was first isolated in 1933 [13],
significant attention has been focused on elucidating its
structure and genome, the immune responses it elicits,
testing protective vaccines, and studying influenza epide-
miology. However, information regarding the kinetics of
influenza virus during an infection within an individual
is limited. Human influenza infections are generally
characterized by exponential growth of the virus, which
peaks 2 to 3 days DPI, followed by an exponential
decrease in the viral load until the virus is undetectable
6 to 8 DPI [14].
During influenza infection, virus shed in nasal and
oropharyngeal secretions and dispersed through sneez-
ing and coughing. Since the duration of shedding and
the quantity of virus shed are important determinants
of infectivity, treatment strategies for influenza should
consider not just symptom reduction but also focus on
reducing infectivity. The results of this study are also
applicable to animal clinics that experience canine
influenza cases. Veterinarians should segregate those
animals suspected of carrying influenza that show a
high fever (>39.5°C) and thus may spread high viral
loads by nasal shedding. It has not yet been elucidated
why the severity of clinical signs, especially fever, is
closely related to levels of viral shedding in infected
animals. This should be further studied with regard to
the variability of inflammatory and immune responses
in CIV-infected hosts. In similar study of viral shed-
ding in human after infection of pandemic H1N1, viral
load was maintained at a high level during the febrile
period. And pandemic flu-infected patients with pneu-
monia had a higher viral load than those with mild
lesion related with flu. The higher viral shedding load
may be a reflection of disease severity, or impaired
host defense mechanism, need immediate attention
and treatment [15].
The data above show that dogs that commingle with a
canine influenza infected dog shed different levels of
virus in their nasal excretions. The correlation between
the viral shedding and clinical signs of canine influenza
H3N2 virus infection would provide important knowl-
edge for epidemiological control and clinical manage-
ment in terms of infection control strategy.
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